Valuation: Natera, Inc.

Capitalization 2.74TCr 2.33TCr 2.16TCr 2.03TCr 3.78TCr 2,54400Cr 3.86TCr 25TCr 9.9TCr 1,22200Cr 10TCr 10TCr 4,35400Cr P/E ratio 2026 *
-105x
P/E ratio 2027 * -299x
Enterprise value 2.64TCr 2.25TCr 2.08TCr 1.96TCr 3.65TCr 2,45200Cr 3.72TCr 24TCr 9.54TCr 1,17700Cr 9.89TCr 9.68TCr 4,19500Cr EV / Sales 2026 *
9.87x
EV / Sales 2027 * 8.18x
Free-Float
96.31%
Yield 2026 *
-
Yield 2027 * -
1 day-4.91%
1 week-7.19%
Current month-3.48%
1 month-1.82%
3 months-17.62%
6 months+14.04%
Current year-15.74%
1 week 184
Extreme 184
220
1 month 181
Extreme 181
220
Current year 181
Extreme 181
256.36
1 year 131.81
Extreme 131.8106
256.36
3 years 36.9
Extreme 36.9
256.36
5 years 26.1
Extreme 26.1
256.36
10 years 7.35
Extreme 7.35
256.36
Manager TitleAgeSince
Chief Executive Officer 47 02/01/2019
Director of Finance/CFO 46 01/02/2017
Compliance Officer - 01/08/2017
Director TitleAgeSince
Chairman 53 01/05/2015
Director/Board Member 53 01/01/2007
Director/Board Member 47 02/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
-4.91%-7.19%+30.39%+271.43% 2.74TCr
-0.50%-1.05%-20.28%-45.60% 692.25Cr
-1.14%+1.17%+3.78%+102.97% 430.2Cr
+0.68%+5.72%+3.98%+50.93% 252.39Cr
+2.73%+6.55%+40.77%+22.27% 183.79Cr
+1.49%+2.23%-10.94%-70.40% 180.54Cr
-0.72%-9.94%-38.30%+489.26% 174.62Cr
+0.43%+3.02%+32.32%-35.72% 167.81Cr
+0.70%-2.04% - - 158.85Cr
-2.71%-2.98%+21.03%+16.15% 108.86Cr
Average -0.40%-0.18%+6.97%+89.03% 508.52Cr
Weighted average by Cap. -2.67%-3.60%+15.89%+170.66%

Financials

2026 *2027 *
Net sales 267.06Cr 227.5Cr 210.55Cr 198.25Cr 369.26Cr 25TCr 376.83Cr 2.47TCr 966.46Cr 12TCr 1TCr 980.95Cr 42TCr 319.47Cr 272.16Cr 251.87Cr 237.16Cr 441.74Cr 30TCr 450.79Cr 2.95TCr 1.16TCr 14TCr 1.2TCr 1.17TCr 51TCr
Net income -25Cr -21Cr -20Cr -18Cr -34Cr -2.31TCr -35Cr -230.21Cr -90Cr -1.11TCr -93Cr -91Cr -3.96TCr -6.03Cr -5.13Cr -4.75Cr -4.47Cr -8.33Cr -560.41Cr -8.5Cr -56Cr -22Cr -269.11Cr -23Cr -22Cr -958.85Cr
Net Debt -100Cr -85Cr -78Cr -74Cr -137.62Cr -9.26TCr -140.44Cr -920.56Cr -360.2Cr -4.45TCr -373.51Cr -365.6Cr -16TCr -123.11Cr -104.88Cr -97Cr -91Cr -170.23Cr -11TCr -173.72Cr -1.14TCr -445.54Cr -5.5TCr -462.01Cr -452.22Cr -20TCr
Logo Natera, Inc.
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.
Employees
6,138
Date Price Change Volume
10/26/10 193.03 $ -4.91% 28,71,768
09/26/09 203.00 $ -3.71% 14,90,869
08/26/08 210.83 $ +0.75% 10,94,586
07/26/07 209.27 $ +2.15% 9,06,452
06/26/06 204.87 $ -1.50% 8,08,942
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
193.03USD
Average target price
258.58USD
Spread / Average Target
+33.96%

Quarterly revenue - Rate of surprise